Related references
Note: Only part of the references are listed.A Humanized Immunoenzyme with Enhanced Activity for Glucuronide Prodrug Activation in the Tumor Microenvironment
Kai-Chuan Chen et al.
BIOCONJUGATE CHEMISTRY (2011)
Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a beta-galactosidase-activatable prodrug seco-analog of duocarmycin SA
C. M. Seubert et al.
CANCER GENE THERAPY (2011)
Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β-glucuronidase in tumors
P-T Huang et al.
CANCER GENE THERAPY (2011)
Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus
Dana Haddad et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
Jeong Heo et al.
MOLECULAR THERAPY (2011)
Synthesis and Evaluation of [18F]-FEAnGA as a PET Tracer for β-Glucuronidase Activity
Ines F. Antunes et al.
BIOCONJUGATE CHEMISTRY (2010)
Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent
I. Gentschev et al.
CANCER GENE THERAPY (2009)
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms
Katharina A. Sterenczak et al.
GENE (2009)
Micro-PET Imaging of beta-Glucuronidase Activity by the Hydrophobic Conversion of a Glucuronide Probe
Shey-Cherng Tzou et al.
RADIOLOGY (2009)
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
David H. Kirn et al.
NATURE REVIEWS CANCER (2009)
Tumor-targeting prodrug-activating bacteria for cancer therapy
C-M Cheng et al.
CANCER GENE THERAPY (2008)
Directed Evolution of a Lysosomal Enzyme with Enhanced Activity at Neutral pH by Mammalian Cell-Surface Display
Kai-Chuan Chen et al.
CHEMISTRY & BIOLOGY (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma
Ta-Chiang Liu et al.
MOLECULAR THERAPY (2008)
Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus
Qian Zhang et al.
CANCER RESEARCH (2007)
Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice
Jochen Stritzker et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Gene expression imaging by enzymatic catalysis of a fluorescent probe via membrane-anchored β-glucuronidase
Y-C Su et al.
GENE THERAPY (2007)
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
YA Yu et al.
NATURE BIOTECHNOLOGY (2004)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein
M De Graaf et al.
HUMAN GENE THERAPY (2004)
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer
JJ Bennett et al.
NATURE MEDICINE (2001)
Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy
D Heine et al.
GENE THERAPY (2001)
Secreted human β-glucuronidase:: a novel tool for gene-directed enzyme prodrug therapy
D Weyel et al.
GENE THERAPY (2000)
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant
M Puhlmann et al.
CANCER GENE THERAPY (2000)
Share Paper
